• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    2.89 Up 0.13(4.71%) Aug 28, 4:00PM EDT
    |After Hours : 2.89 0.00 (0.00%) Aug 28, 4:29PM EDT
    Add to Portfolio
    Prev Close:2.76
    Open:2.72
    Bid:2.40 x 100
    Ask:2.99 x 1000
    1y Target Est:12.00
    Beta:1.55323
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:2.72 - 2.94
    52wk Range:2.62 - 9.37
    Volume:2,015,332
    Avg Vol (3m):2,323,790
    Market Cap:362.39M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 4.71%362.39M
    ABTUp 0.83%68.59B
    GSKUp 0.10%99.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.65
    Quarterly EPS Est (Sep-15) :-0.15
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback